{"id":516,"date":"2024-11-15T15:47:47","date_gmt":"2024-11-15T20:47:47","guid":{"rendered":"https:\/\/www.mgocpa.com\/?post_type=solution-industry&p=516"},"modified":"2024-12-10T20:06:12","modified_gmt":"2024-12-11T01:06:12","slug":"orphan-drug-credit","status":"publish","type":"solution-industry","link":"https:\/\/www.mgocpa.com\/solution-industry\/orphan-drug-credit\/","title":{"rendered":"Orphan Drug Credit"},"content":{"rendered":"\n
\n
\n

Power Your Efforts to Develop Treatments for Rare Diseases<\/h2>\n<\/header>\n\n\n\n

Pharmaceutical companies face significant financial challenges when developing treatments for rare diseases, often called \u201corphan diseases\u201d. With limited patient populations, these endeavors can seem economically unviable. The Orphan Drug Tax Credit (ODC) addresses this by offering a substantial tax incentive to encourage investment in life-saving treatments.<\/p>\n<\/section>\n\n\n\n

\n
\n
\n

Key Benefits of the Orphan Drug Credit<\/h2>\n<\/div>\n\n\n\n
\n
Significant Tax Savings<\/summary>\n


The ODC allows you to claim up to 25% of qualified clinical testing expenses, making it easier to invest in orphan drug development.<\/p>\n<\/details>\n\n\n\n

Comprehensive Coverage<\/summary>\n

The ODC covers 100% of qualified contract research expenses and includes foreign clinical testing expenses under certain conditions.<\/p>\n<\/details>\n\n\n\n

Dual Tax Credit Opportunities<\/summary>\n

Your company can claim R&D and ODC credits in the same tax year (provided you meet the criteria for each), maximizing financial support for diverse medical research.<\/p>\n<\/details>\n\n\n\n

Extended Support Timeline<\/summary>\n

You can claim the ODC for expenses from the Federal Drug Administration\u2019s (FDAs) orphan drug designation date to the drug\u2019s approval date, ensuring extended financial support.<\/p>\n<\/details>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\n

Our Perspective, Your Benefit<\/h2>\n<\/div>\n\n\n\n
\n
\n
See all Perspectives<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tAnswers to Your FAQs About Section 174 R&D Expensing\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/h3>\n\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tIRS<\/span>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"Lab <\/picture>\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tHow to Align Your Global Supply Chain and International Tax Strategy\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/h3>\n\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tCross Border Transactions<\/span>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"Aerial <\/picture>\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tFrequently Asked Questions About International Tax and Supply Chain Realignment\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/h3>\n\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tCross Border Transactions<\/span>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"Worldwide, <\/picture>\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tUnlock Bigger R&D Tax Credits for Your Texas Business\u00a0\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/h3>\n\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tR&D<\/span>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"image <\/picture>\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tClaiming R&D Tax Credits for Your Architecture, Engineering, or Design-Build Firm\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/h3>\n\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tIRS<\/span>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"Workers <\/picture>\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tMaximizing the R&D Tax Credit: A Guide for Innovation-Driven Businesses\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/h3>\n\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tManufacturing<\/span>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"Technical <\/picture>\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\n\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
\n

Leaders ready to serve you<\/h2>\n<\/div>\n\n\n\n
\n

As you grow, you face complex risks and opportunities. Benefit from hands-on guidance focused on delivering top-to-bottom value for you and your organization.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"Photo <\/picture>\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\tDanielle Bradley, MBA\t\t\t\t\t\t\t\t<\/h3>\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

National Credits and Incentives Leader | Director and National Biotech & Lifesciences Industry Leader<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead bio\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tRead Danielle Bradley, MBA’s bio\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\tVisit Danielle Bradley, MBA’s LinkedIn profile\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"Photo <\/picture>\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\tMichael Silvio, CPA\t\t\t\t\t\t\t\t<\/h3>\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

Tax Partner<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead bio\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tRead Michael Silvio, CPA’s bio\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\tVisit Michael Silvio, CPA’s LinkedIn profile\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\n\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
\n

Related Solutions<\/h2>\n<\/div>\n\n\n\n
\n
\n
See all solutions<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\"Image <\/picture>\t\t\n\t\t\t\t\t
\n\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\tR&D Tax Credits\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t

Power innovation by reducing tax liability through state and federal R&D credits.<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/article>\n\t\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\"Image <\/picture>\t\t\n\t\t\t\t\t
\n\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\tTax Credits and Incentives\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t

Put your profits back where they belong: driving expansion and innovation for your organization. With experienced guidance credits and incentives can be a powerful tool for fueling your growth.<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/article>\n\t\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\"Image <\/picture>\t\t\n\t\t\t\t\t
\n\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\tEnterprise Business Tax\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t

Your goal is to drive growth on a large scale. Our goal is to identify strategic opportunities, streamline complexities, and deliver tax solutions that align with your enterprise’s needs.<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/article>\n\t\t\t\t\t<\/div>\n<\/div><\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Power Your Efforts to Develop Treatments for Rare Diseases Pharmaceutical companies face significant financial challenges when developing treatments for rare diseases, often called \u201corphan diseases\u201d. With limited patient populations, these endeavors can seem economically unviable. The Orphan Drug Tax Credit (ODC) addresses this by offering a substantial tax incentive to encourage investment in life-saving treatments. […]<\/p>\n","protected":false},"featured_media":517,"template":"","meta":{"_acf_changed":true,"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"goal":[],"solution-category":[],"class_list":["post-516","solution-industry","type-solution-industry","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nOrphan Drug Credit - MGO CPA | Tax, Audit, and Consulting Services<\/title>\n<meta name=\"description\" content=\"Support rare disease treatments with the Orphan Drug Credit through MGO CPA. Discover significant tax incentives and foster innovation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Orphan Drug Credit - MGO CPA | Tax, Audit, and Consulting Services\" \/>\n<meta property=\"og:description\" content=\"Support rare disease treatments with the Orphan Drug Credit through MGO CPA. Discover significant tax incentives and foster innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/\" \/>\n<meta property=\"og:site_name\" content=\"MGO CPA | Tax, Audit, and Consulting Services\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/mgocpa\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-11T01:06:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/11\/lab-vials.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1312\" \/>\n\t<meta property=\"og:image:height\" content=\"876\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/\",\"url\":\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/\",\"name\":\"Orphan Drug Credit - MGO CPA | Tax, Audit, and Consulting Services\",\"isPartOf\":{\"@id\":\"https:\/\/www.mgocpa.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/11\/lab-vials.jpg\",\"datePublished\":\"2024-11-15T20:47:47+00:00\",\"dateModified\":\"2024-12-11T01:06:12+00:00\",\"description\":\"Support rare disease treatments with the Orphan Drug Credit through MGO CPA. Discover significant tax incentives and foster innovation.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#primaryimage\",\"url\":\"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/11\/lab-vials.jpg\",\"contentUrl\":\"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/11\/lab-vials.jpg\",\"width\":1312,\"height\":876,\"caption\":\"lab vials\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mgocpa.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Orphan Drug Credit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mgocpa.com\/#website\",\"url\":\"https:\/\/www.mgocpa.com\/\",\"name\":\"MGO CPA\",\"description\":\"Tax, Audit, and Consulting Services\",\"publisher\":{\"@id\":\"https:\/\/www.mgocpa.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mgocpa.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mgocpa.com\/#organization\",\"name\":\"MGO CPA\",\"url\":\"https:\/\/www.mgocpa.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.mgocpa.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/10\/mgocpa-logo.svg\",\"contentUrl\":\"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/10\/mgocpa-logo.svg\",\"width\":134,\"height\":32,\"caption\":\"MGO CPA\"},\"image\":{\"@id\":\"https:\/\/www.mgocpa.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/mgocpa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Orphan Drug Credit - MGO CPA | Tax, Audit, and Consulting Services","description":"Support rare disease treatments with the Orphan Drug Credit through MGO CPA. Discover significant tax incentives and foster innovation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/","og_locale":"en_US","og_type":"article","og_title":"Orphan Drug Credit - MGO CPA | Tax, Audit, and Consulting Services","og_description":"Support rare disease treatments with the Orphan Drug Credit through MGO CPA. Discover significant tax incentives and foster innovation.","og_url":"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/","og_site_name":"MGO CPA | Tax, Audit, and Consulting Services","article_publisher":"https:\/\/www.facebook.com\/mgocpa","article_modified_time":"2024-12-11T01:06:12+00:00","og_image":[{"width":1312,"height":876,"url":"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/11\/lab-vials.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/","url":"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/","name":"Orphan Drug Credit - MGO CPA | Tax, Audit, and Consulting Services","isPartOf":{"@id":"https:\/\/www.mgocpa.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#primaryimage"},"image":{"@id":"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/11\/lab-vials.jpg","datePublished":"2024-11-15T20:47:47+00:00","dateModified":"2024-12-11T01:06:12+00:00","description":"Support rare disease treatments with the Orphan Drug Credit through MGO CPA. Discover significant tax incentives and foster innovation.","breadcrumb":{"@id":"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#primaryimage","url":"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/11\/lab-vials.jpg","contentUrl":"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/11\/lab-vials.jpg","width":1312,"height":876,"caption":"lab vials"},{"@type":"BreadcrumbList","@id":"https:\/\/www.mgocpa.com\/solution-and-industry\/orphan-drug-credit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mgocpa.com\/"},{"@type":"ListItem","position":2,"name":"Orphan Drug Credit"}]},{"@type":"WebSite","@id":"https:\/\/www.mgocpa.com\/#website","url":"https:\/\/www.mgocpa.com\/","name":"MGO CPA","description":"Tax, Audit, and Consulting Services","publisher":{"@id":"https:\/\/www.mgocpa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mgocpa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.mgocpa.com\/#organization","name":"MGO CPA","url":"https:\/\/www.mgocpa.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mgocpa.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/10\/mgocpa-logo.svg","contentUrl":"https:\/\/www.mgocpa.com\/wp-content\/uploads\/2024\/10\/mgocpa-logo.svg","width":134,"height":32,"caption":"MGO CPA"},"image":{"@id":"https:\/\/www.mgocpa.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/mgocpa"]}]}},"_links":{"self":[{"href":"https:\/\/www.mgocpa.com\/wp-json\/wp\/v2\/solution-industry\/516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mgocpa.com\/wp-json\/wp\/v2\/solution-industry"}],"about":[{"href":"https:\/\/www.mgocpa.com\/wp-json\/wp\/v2\/types\/solution-industry"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mgocpa.com\/wp-json\/wp\/v2\/media\/517"}],"wp:attachment":[{"href":"https:\/\/www.mgocpa.com\/wp-json\/wp\/v2\/media?parent=516"}],"wp:term":[{"taxonomy":"goal","embeddable":true,"href":"https:\/\/www.mgocpa.com\/wp-json\/wp\/v2\/goal?post=516"},{"taxonomy":"solution-category","embeddable":true,"href":"https:\/\/www.mgocpa.com\/wp-json\/wp\/v2\/solution-category?post=516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}